Global Synthetic Oligonucleotides Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 130

Published Date: 10 Jan 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Synthetic Oligonucleotides market size was valued at USD 6978.3 million in 2023 and is forecast to a readjusted size of USD 14230 million by 2030 with a CAGR of 10.7% during review period.

The unique ability to specifically bind to the nucleic acid sequence makes oligonucleotide (ON) a promising agent in the medical field. Moreover, the capability of ONs to exert the aforementioned biological mechanisms via sequence-specific molecular recognition makes them highly attractive candidates for drug development.

The Global Info Research report includes an overview of the development of the Synthetic Oligonucleotides industry chain, the market status of Genetic Testing (Column-Based Oligos, Array-Based Oligos), Pharmacy (Column-Based Oligos, Array-Based Oligos), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Synthetic Oligonucleotides.

Regionally, the report analyzes the Synthetic Oligonucleotides markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Synthetic Oligonucleotides market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Synthetic Oligonucleotides market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Synthetic Oligonucleotides industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Column-Based Oligos, Array-Based Oligos).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Synthetic Oligonucleotides market.

Regional Analysis: The report involves examining the Synthetic Oligonucleotides market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Synthetic Oligonucleotides market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Synthetic Oligonucleotides:
Company Analysis: Report covers individual Synthetic Oligonucleotides players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Synthetic Oligonucleotides This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Genetic Testing, Pharmacy).

Technology Analysis: Report covers specific technologies relevant to Synthetic Oligonucleotides. It assesses the current state, advancements, and potential future developments in Synthetic Oligonucleotides areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Synthetic Oligonucleotides market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Synthetic Oligonucleotides market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Column-Based Oligos
Array-Based Oligos

Market segment by Application
Genetic Testing
Pharmacy
Other

Market segment by players, this report covers
Merck KGaA
Thermo Fisher Scientific
Creative Biolabs
Danaher Corporation
Eurofins Scientific SE
Agilent Technologies, Inc.
GE Healthcare
Kaneka Eurogentec S.A.
GeneDesign, Inc.
LGC Biosearch Technologies
Bio-synthesis Inc.
GeneWorks Pty Ltd
Integrated DNA Technologies, Inc
BioAutomation
Twist Bioscience

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Synthetic Oligonucleotides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Synthetic Oligonucleotides, with revenue, gross margin and global market share of Synthetic Oligonucleotides from 2019 to 2024.
Chapter 3, the Synthetic Oligonucleotides competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Synthetic Oligonucleotides market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Synthetic Oligonucleotides.
Chapter 13, to describe Synthetic Oligonucleotides research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Synthetic Oligonucleotides
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Synthetic Oligonucleotides by Type
        1.3.1 Overview: Global Synthetic Oligonucleotides Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Synthetic Oligonucleotides Consumption Value Market Share by Type in 2023
        1.3.3 Column-Based Oligos
        1.3.4 Array-Based Oligos
    1.4 Global Synthetic Oligonucleotides Market by Application
        1.4.1 Overview: Global Synthetic Oligonucleotides Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Genetic Testing
        1.4.3 Pharmacy
        1.4.4 Other
    1.5 Global Synthetic Oligonucleotides Market Size & Forecast
    1.6 Global Synthetic Oligonucleotides Market Size and Forecast by Region
        1.6.1 Global Synthetic Oligonucleotides Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Synthetic Oligonucleotides Market Size by Region, (2019-2030)
        1.6.3 North America Synthetic Oligonucleotides Market Size and Prospect (2019-2030)
        1.6.4 Europe Synthetic Oligonucleotides Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Synthetic Oligonucleotides Market Size and Prospect (2019-2030)
        1.6.6 South America Synthetic Oligonucleotides Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Synthetic Oligonucleotides Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Merck KGaA
        2.1.1 Merck KGaA Details
        2.1.2 Merck KGaA Major Business
        2.1.3 Merck KGaA Synthetic Oligonucleotides Product and Solutions
        2.1.4 Merck KGaA Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Merck KGaA Recent Developments and Future Plans
    2.2 Thermo Fisher Scientific
        2.2.1 Thermo Fisher Scientific Details
        2.2.2 Thermo Fisher Scientific Major Business
        2.2.3 Thermo Fisher Scientific Synthetic Oligonucleotides Product and Solutions
        2.2.4 Thermo Fisher Scientific Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
    2.3 Creative Biolabs
        2.3.1 Creative Biolabs Details
        2.3.2 Creative Biolabs Major Business
        2.3.3 Creative Biolabs Synthetic Oligonucleotides Product and Solutions
        2.3.4 Creative Biolabs Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Creative Biolabs Recent Developments and Future Plans
    2.4 Danaher Corporation
        2.4.1 Danaher Corporation Details
        2.4.2 Danaher Corporation Major Business
        2.4.3 Danaher Corporation Synthetic Oligonucleotides Product and Solutions
        2.4.4 Danaher Corporation Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Danaher Corporation Recent Developments and Future Plans
    2.5 Eurofins Scientific SE
        2.5.1 Eurofins Scientific SE Details
        2.5.2 Eurofins Scientific SE Major Business
        2.5.3 Eurofins Scientific SE Synthetic Oligonucleotides Product and Solutions
        2.5.4 Eurofins Scientific SE Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Eurofins Scientific SE Recent Developments and Future Plans
    2.6 Agilent Technologies, Inc.
        2.6.1 Agilent Technologies, Inc. Details
        2.6.2 Agilent Technologies, Inc. Major Business
        2.6.3 Agilent Technologies, Inc. Synthetic Oligonucleotides Product and Solutions
        2.6.4 Agilent Technologies, Inc. Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Agilent Technologies, Inc. Recent Developments and Future Plans
    2.7 GE Healthcare
        2.7.1 GE Healthcare Details
        2.7.2 GE Healthcare Major Business
        2.7.3 GE Healthcare Synthetic Oligonucleotides Product and Solutions
        2.7.4 GE Healthcare Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 GE Healthcare Recent Developments and Future Plans
    2.8 Kaneka Eurogentec S.A.
        2.8.1 Kaneka Eurogentec S.A. Details
        2.8.2 Kaneka Eurogentec S.A. Major Business
        2.8.3 Kaneka Eurogentec S.A. Synthetic Oligonucleotides Product and Solutions
        2.8.4 Kaneka Eurogentec S.A. Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Kaneka Eurogentec S.A. Recent Developments and Future Plans
    2.9 GeneDesign, Inc.
        2.9.1 GeneDesign, Inc. Details
        2.9.2 GeneDesign, Inc. Major Business
        2.9.3 GeneDesign, Inc. Synthetic Oligonucleotides Product and Solutions
        2.9.4 GeneDesign, Inc. Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 GeneDesign, Inc. Recent Developments and Future Plans
    2.10 LGC Biosearch Technologies
        2.10.1 LGC Biosearch Technologies Details
        2.10.2 LGC Biosearch Technologies Major Business
        2.10.3 LGC Biosearch Technologies Synthetic Oligonucleotides Product and Solutions
        2.10.4 LGC Biosearch Technologies Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 LGC Biosearch Technologies Recent Developments and Future Plans
    2.11 Bio-synthesis Inc.
        2.11.1 Bio-synthesis Inc. Details
        2.11.2 Bio-synthesis Inc. Major Business
        2.11.3 Bio-synthesis Inc. Synthetic Oligonucleotides Product and Solutions
        2.11.4 Bio-synthesis Inc. Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Bio-synthesis Inc. Recent Developments and Future Plans
    2.12 GeneWorks Pty Ltd
        2.12.1 GeneWorks Pty Ltd Details
        2.12.2 GeneWorks Pty Ltd Major Business
        2.12.3 GeneWorks Pty Ltd Synthetic Oligonucleotides Product and Solutions
        2.12.4 GeneWorks Pty Ltd Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 GeneWorks Pty Ltd Recent Developments and Future Plans
    2.13 Integrated DNA Technologies, Inc
        2.13.1 Integrated DNA Technologies, Inc Details
        2.13.2 Integrated DNA Technologies, Inc Major Business
        2.13.3 Integrated DNA Technologies, Inc Synthetic Oligonucleotides Product and Solutions
        2.13.4 Integrated DNA Technologies, Inc Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Integrated DNA Technologies, Inc Recent Developments and Future Plans
    2.14 BioAutomation
        2.14.1 BioAutomation Details
        2.14.2 BioAutomation Major Business
        2.14.3 BioAutomation Synthetic Oligonucleotides Product and Solutions
        2.14.4 BioAutomation Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 BioAutomation Recent Developments and Future Plans
    2.15 Twist Bioscience
        2.15.1 Twist Bioscience Details
        2.15.2 Twist Bioscience Major Business
        2.15.3 Twist Bioscience Synthetic Oligonucleotides Product and Solutions
        2.15.4 Twist Bioscience Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 Twist Bioscience Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Synthetic Oligonucleotides Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Synthetic Oligonucleotides by Company Revenue
        3.2.2 Top 3 Synthetic Oligonucleotides Players Market Share in 2023
        3.2.3 Top 6 Synthetic Oligonucleotides Players Market Share in 2023
    3.3 Synthetic Oligonucleotides Market: Overall Company Footprint Analysis
        3.3.1 Synthetic Oligonucleotides Market: Region Footprint
        3.3.2 Synthetic Oligonucleotides Market: Company Product Type Footprint
        3.3.3 Synthetic Oligonucleotides Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Synthetic Oligonucleotides Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Synthetic Oligonucleotides Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Synthetic Oligonucleotides Consumption Value Market Share by Application (2019-2024)
    5.2 Global Synthetic Oligonucleotides Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Synthetic Oligonucleotides Consumption Value by Type (2019-2030)
    6.2 North America Synthetic Oligonucleotides Consumption Value by Application (2019-2030)
    6.3 North America Synthetic Oligonucleotides Market Size by Country
        6.3.1 North America Synthetic Oligonucleotides Consumption Value by Country (2019-2030)
        6.3.2 United States Synthetic Oligonucleotides Market Size and Forecast (2019-2030)
        6.3.3 Canada Synthetic Oligonucleotides Market Size and Forecast (2019-2030)
        6.3.4 Mexico Synthetic Oligonucleotides Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Synthetic Oligonucleotides Consumption Value by Type (2019-2030)
    7.2 Europe Synthetic Oligonucleotides Consumption Value by Application (2019-2030)
    7.3 Europe Synthetic Oligonucleotides Market Size by Country
        7.3.1 Europe Synthetic Oligonucleotides Consumption Value by Country (2019-2030)
        7.3.2 Germany Synthetic Oligonucleotides Market Size and Forecast (2019-2030)
        7.3.3 France Synthetic Oligonucleotides Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Synthetic Oligonucleotides Market Size and Forecast (2019-2030)
        7.3.5 Russia Synthetic Oligonucleotides Market Size and Forecast (2019-2030)
        7.3.6 Italy Synthetic Oligonucleotides Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Synthetic Oligonucleotides Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Synthetic Oligonucleotides Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Synthetic Oligonucleotides Market Size by Region
        8.3.1 Asia-Pacific Synthetic Oligonucleotides Consumption Value by Region (2019-2030)
        8.3.2 China Synthetic Oligonucleotides Market Size and Forecast (2019-2030)
        8.3.3 Japan Synthetic Oligonucleotides Market Size and Forecast (2019-2030)
        8.3.4 South Korea Synthetic Oligonucleotides Market Size and Forecast (2019-2030)
        8.3.5 India Synthetic Oligonucleotides Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Synthetic Oligonucleotides Market Size and Forecast (2019-2030)
        8.3.7 Australia Synthetic Oligonucleotides Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Synthetic Oligonucleotides Consumption Value by Type (2019-2030)
    9.2 South America Synthetic Oligonucleotides Consumption Value by Application (2019-2030)
    9.3 South America Synthetic Oligonucleotides Market Size by Country
        9.3.1 South America Synthetic Oligonucleotides Consumption Value by Country (2019-2030)
        9.3.2 Brazil Synthetic Oligonucleotides Market Size and Forecast (2019-2030)
        9.3.3 Argentina Synthetic Oligonucleotides Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Synthetic Oligonucleotides Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Synthetic Oligonucleotides Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Synthetic Oligonucleotides Market Size by Country
        10.3.1 Middle East & Africa Synthetic Oligonucleotides Consumption Value by Country (2019-2030)
        10.3.2 Turkey Synthetic Oligonucleotides Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Synthetic Oligonucleotides Market Size and Forecast (2019-2030)
        10.3.4 UAE Synthetic Oligonucleotides Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Synthetic Oligonucleotides Market Drivers
    11.2 Synthetic Oligonucleotides Market Restraints
    11.3 Synthetic Oligonucleotides Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Synthetic Oligonucleotides Industry Chain
    12.2 Synthetic Oligonucleotides Upstream Analysis
    12.3 Synthetic Oligonucleotides Midstream Analysis
    12.4 Synthetic Oligonucleotides Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Synthetic Oligonucleotides Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Synthetic Oligonucleotides Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Synthetic Oligonucleotides Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Synthetic Oligonucleotides Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Merck KGaA Company Information, Head Office, and Major Competitors
    Table 6. Merck KGaA Major Business
    Table 7. Merck KGaA Synthetic Oligonucleotides Product and Solutions
    Table 8. Merck KGaA Synthetic Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Merck KGaA Recent Developments and Future Plans
    Table 10. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
    Table 11. Thermo Fisher Scientific Major Business
    Table 12. Thermo Fisher Scientific Synthetic Oligonucleotides Product and Solutions
    Table 13. Thermo Fisher Scientific Synthetic Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Thermo Fisher Scientific Recent Developments and Future Plans
    Table 15. Creative Biolabs Company Information, Head Office, and Major Competitors
    Table 16. Creative Biolabs Major Business
    Table 17. Creative Biolabs Synthetic Oligonucleotides Product and Solutions
    Table 18. Creative Biolabs Synthetic Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Creative Biolabs Recent Developments and Future Plans
    Table 20. Danaher Corporation Company Information, Head Office, and Major Competitors
    Table 21. Danaher Corporation Major Business
    Table 22. Danaher Corporation Synthetic Oligonucleotides Product and Solutions
    Table 23. Danaher Corporation Synthetic Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Danaher Corporation Recent Developments and Future Plans
    Table 25. Eurofins Scientific SE Company Information, Head Office, and Major Competitors
    Table 26. Eurofins Scientific SE Major Business
    Table 27. Eurofins Scientific SE Synthetic Oligonucleotides Product and Solutions
    Table 28. Eurofins Scientific SE Synthetic Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Eurofins Scientific SE Recent Developments and Future Plans
    Table 30. Agilent Technologies, Inc. Company Information, Head Office, and Major Competitors
    Table 31. Agilent Technologies, Inc. Major Business
    Table 32. Agilent Technologies, Inc. Synthetic Oligonucleotides Product and Solutions
    Table 33. Agilent Technologies, Inc. Synthetic Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Agilent Technologies, Inc. Recent Developments and Future Plans
    Table 35. GE Healthcare Company Information, Head Office, and Major Competitors
    Table 36. GE Healthcare Major Business
    Table 37. GE Healthcare Synthetic Oligonucleotides Product and Solutions
    Table 38. GE Healthcare Synthetic Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. GE Healthcare Recent Developments and Future Plans
    Table 40. Kaneka Eurogentec S.A. Company Information, Head Office, and Major Competitors
    Table 41. Kaneka Eurogentec S.A. Major Business
    Table 42. Kaneka Eurogentec S.A. Synthetic Oligonucleotides Product and Solutions
    Table 43. Kaneka Eurogentec S.A. Synthetic Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Kaneka Eurogentec S.A. Recent Developments and Future Plans
    Table 45. GeneDesign, Inc. Company Information, Head Office, and Major Competitors
    Table 46. GeneDesign, Inc. Major Business
    Table 47. GeneDesign, Inc. Synthetic Oligonucleotides Product and Solutions
    Table 48. GeneDesign, Inc. Synthetic Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. GeneDesign, Inc. Recent Developments and Future Plans
    Table 50. LGC Biosearch Technologies Company Information, Head Office, and Major Competitors
    Table 51. LGC Biosearch Technologies Major Business
    Table 52. LGC Biosearch Technologies Synthetic Oligonucleotides Product and Solutions
    Table 53. LGC Biosearch Technologies Synthetic Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. LGC Biosearch Technologies Recent Developments and Future Plans
    Table 55. Bio-synthesis Inc. Company Information, Head Office, and Major Competitors
    Table 56. Bio-synthesis Inc. Major Business
    Table 57. Bio-synthesis Inc. Synthetic Oligonucleotides Product and Solutions
    Table 58. Bio-synthesis Inc. Synthetic Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. Bio-synthesis Inc. Recent Developments and Future Plans
    Table 60. GeneWorks Pty Ltd Company Information, Head Office, and Major Competitors
    Table 61. GeneWorks Pty Ltd Major Business
    Table 62. GeneWorks Pty Ltd Synthetic Oligonucleotides Product and Solutions
    Table 63. GeneWorks Pty Ltd Synthetic Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. GeneWorks Pty Ltd Recent Developments and Future Plans
    Table 65. Integrated DNA Technologies, Inc Company Information, Head Office, and Major Competitors
    Table 66. Integrated DNA Technologies, Inc Major Business
    Table 67. Integrated DNA Technologies, Inc Synthetic Oligonucleotides Product and Solutions
    Table 68. Integrated DNA Technologies, Inc Synthetic Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. Integrated DNA Technologies, Inc Recent Developments and Future Plans
    Table 70. BioAutomation Company Information, Head Office, and Major Competitors
    Table 71. BioAutomation Major Business
    Table 72. BioAutomation Synthetic Oligonucleotides Product and Solutions
    Table 73. BioAutomation Synthetic Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 74. BioAutomation Recent Developments and Future Plans
    Table 75. Twist Bioscience Company Information, Head Office, and Major Competitors
    Table 76. Twist Bioscience Major Business
    Table 77. Twist Bioscience Synthetic Oligonucleotides Product and Solutions
    Table 78. Twist Bioscience Synthetic Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 79. Twist Bioscience Recent Developments and Future Plans
    Table 80. Global Synthetic Oligonucleotides Revenue (USD Million) by Players (2019-2024)
    Table 81. Global Synthetic Oligonucleotides Revenue Share by Players (2019-2024)
    Table 82. Breakdown of Synthetic Oligonucleotides by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 83. Market Position of Players in Synthetic Oligonucleotides, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 84. Head Office of Key Synthetic Oligonucleotides Players
    Table 85. Synthetic Oligonucleotides Market: Company Product Type Footprint
    Table 86. Synthetic Oligonucleotides Market: Company Product Application Footprint
    Table 87. Synthetic Oligonucleotides New Market Entrants and Barriers to Market Entry
    Table 88. Synthetic Oligonucleotides Mergers, Acquisition, Agreements, and Collaborations
    Table 89. Global Synthetic Oligonucleotides Consumption Value (USD Million) by Type (2019-2024)
    Table 90. Global Synthetic Oligonucleotides Consumption Value Share by Type (2019-2024)
    Table 91. Global Synthetic Oligonucleotides Consumption Value Forecast by Type (2025-2030)
    Table 92. Global Synthetic Oligonucleotides Consumption Value by Application (2019-2024)
    Table 93. Global Synthetic Oligonucleotides Consumption Value Forecast by Application (2025-2030)
    Table 94. North America Synthetic Oligonucleotides Consumption Value by Type (2019-2024) & (USD Million)
    Table 95. North America Synthetic Oligonucleotides Consumption Value by Type (2025-2030) & (USD Million)
    Table 96. North America Synthetic Oligonucleotides Consumption Value by Application (2019-2024) & (USD Million)
    Table 97. North America Synthetic Oligonucleotides Consumption Value by Application (2025-2030) & (USD Million)
    Table 98. North America Synthetic Oligonucleotides Consumption Value by Country (2019-2024) & (USD Million)
    Table 99. North America Synthetic Oligonucleotides Consumption Value by Country (2025-2030) & (USD Million)
    Table 100. Europe Synthetic Oligonucleotides Consumption Value by Type (2019-2024) & (USD Million)
    Table 101. Europe Synthetic Oligonucleotides Consumption Value by Type (2025-2030) & (USD Million)
    Table 102. Europe Synthetic Oligonucleotides Consumption Value by Application (2019-2024) & (USD Million)
    Table 103. Europe Synthetic Oligonucleotides Consumption Value by Application (2025-2030) & (USD Million)
    Table 104. Europe Synthetic Oligonucleotides Consumption Value by Country (2019-2024) & (USD Million)
    Table 105. Europe Synthetic Oligonucleotides Consumption Value by Country (2025-2030) & (USD Million)
    Table 106. Asia-Pacific Synthetic Oligonucleotides Consumption Value by Type (2019-2024) & (USD Million)
    Table 107. Asia-Pacific Synthetic Oligonucleotides Consumption Value by Type (2025-2030) & (USD Million)
    Table 108. Asia-Pacific Synthetic Oligonucleotides Consumption Value by Application (2019-2024) & (USD Million)
    Table 109. Asia-Pacific Synthetic Oligonucleotides Consumption Value by Application (2025-2030) & (USD Million)
    Table 110. Asia-Pacific Synthetic Oligonucleotides Consumption Value by Region (2019-2024) & (USD Million)
    Table 111. Asia-Pacific Synthetic Oligonucleotides Consumption Value by Region (2025-2030) & (USD Million)
    Table 112. South America Synthetic Oligonucleotides Consumption Value by Type (2019-2024) & (USD Million)
    Table 113. South America Synthetic Oligonucleotides Consumption Value by Type (2025-2030) & (USD Million)
    Table 114. South America Synthetic Oligonucleotides Consumption Value by Application (2019-2024) & (USD Million)
    Table 115. South America Synthetic Oligonucleotides Consumption Value by Application (2025-2030) & (USD Million)
    Table 116. South America Synthetic Oligonucleotides Consumption Value by Country (2019-2024) & (USD Million)
    Table 117. South America Synthetic Oligonucleotides Consumption Value by Country (2025-2030) & (USD Million)
    Table 118. Middle East & Africa Synthetic Oligonucleotides Consumption Value by Type (2019-2024) & (USD Million)
    Table 119. Middle East & Africa Synthetic Oligonucleotides Consumption Value by Type (2025-2030) & (USD Million)
    Table 120. Middle East & Africa Synthetic Oligonucleotides Consumption Value by Application (2019-2024) & (USD Million)
    Table 121. Middle East & Africa Synthetic Oligonucleotides Consumption Value by Application (2025-2030) & (USD Million)
    Table 122. Middle East & Africa Synthetic Oligonucleotides Consumption Value by Country (2019-2024) & (USD Million)
    Table 123. Middle East & Africa Synthetic Oligonucleotides Consumption Value by Country (2025-2030) & (USD Million)
    Table 124. Synthetic Oligonucleotides Raw Material
    Table 125. Key Suppliers of Synthetic Oligonucleotides Raw Materials
List of Figures
    Figure 1. Synthetic Oligonucleotides Picture
    Figure 2. Global Synthetic Oligonucleotides Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Synthetic Oligonucleotides Consumption Value Market Share by Type in 2023
    Figure 4. Column-Based Oligos
    Figure 5. Array-Based Oligos
    Figure 6. Global Synthetic Oligonucleotides Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 7. Synthetic Oligonucleotides Consumption Value Market Share by Application in 2023
    Figure 8. Genetic Testing Picture
    Figure 9. Pharmacy Picture
    Figure 10. Other Picture
    Figure 11. Global Synthetic Oligonucleotides Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 12. Global Synthetic Oligonucleotides Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 13. Global Market Synthetic Oligonucleotides Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 14. Global Synthetic Oligonucleotides Consumption Value Market Share by Region (2019-2030)
    Figure 15. Global Synthetic Oligonucleotides Consumption Value Market Share by Region in 2023
    Figure 16. North America Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 17. Europe Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 18. Asia-Pacific Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 19. South America Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 20. Middle East and Africa Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 21. Global Synthetic Oligonucleotides Revenue Share by Players in 2023
    Figure 22. Synthetic Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 23. Global Top 3 Players Synthetic Oligonucleotides Market Share in 2023
    Figure 24. Global Top 6 Players Synthetic Oligonucleotides Market Share in 2023
    Figure 25. Global Synthetic Oligonucleotides Consumption Value Share by Type (2019-2024)
    Figure 26. Global Synthetic Oligonucleotides Market Share Forecast by Type (2025-2030)
    Figure 27. Global Synthetic Oligonucleotides Consumption Value Share by Application (2019-2024)
    Figure 28. Global Synthetic Oligonucleotides Market Share Forecast by Application (2025-2030)
    Figure 29. North America Synthetic Oligonucleotides Consumption Value Market Share by Type (2019-2030)
    Figure 30. North America Synthetic Oligonucleotides Consumption Value Market Share by Application (2019-2030)
    Figure 31. North America Synthetic Oligonucleotides Consumption Value Market Share by Country (2019-2030)
    Figure 32. United States Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 33. Canada Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 34. Mexico Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 35. Europe Synthetic Oligonucleotides Consumption Value Market Share by Type (2019-2030)
    Figure 36. Europe Synthetic Oligonucleotides Consumption Value Market Share by Application (2019-2030)
    Figure 37. Europe Synthetic Oligonucleotides Consumption Value Market Share by Country (2019-2030)
    Figure 38. Germany Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 39. France Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 40. United Kingdom Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 41. Russia Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 42. Italy Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 43. Asia-Pacific Synthetic Oligonucleotides Consumption Value Market Share by Type (2019-2030)
    Figure 44. Asia-Pacific Synthetic Oligonucleotides Consumption Value Market Share by Application (2019-2030)
    Figure 45. Asia-Pacific Synthetic Oligonucleotides Consumption Value Market Share by Region (2019-2030)
    Figure 46. China Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 47. Japan Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 48. South Korea Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 49. India Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 50. Southeast Asia Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 51. Australia Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 52. South America Synthetic Oligonucleotides Consumption Value Market Share by Type (2019-2030)
    Figure 53. South America Synthetic Oligonucleotides Consumption Value Market Share by Application (2019-2030)
    Figure 54. South America Synthetic Oligonucleotides Consumption Value Market Share by Country (2019-2030)
    Figure 55. Brazil Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 56. Argentina Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 57. Middle East and Africa Synthetic Oligonucleotides Consumption Value Market Share by Type (2019-2030)
    Figure 58. Middle East and Africa Synthetic Oligonucleotides Consumption Value Market Share by Application (2019-2030)
    Figure 59. Middle East and Africa Synthetic Oligonucleotides Consumption Value Market Share by Country (2019-2030)
    Figure 60. Turkey Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 61. Saudi Arabia Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 62. UAE Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 63. Synthetic Oligonucleotides Market Drivers
    Figure 64. Synthetic Oligonucleotides Market Restraints
    Figure 65. Synthetic Oligonucleotides Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Synthetic Oligonucleotides in 2023
    Figure 68. Manufacturing Process Analysis of Synthetic Oligonucleotides
    Figure 69. Synthetic Oligonucleotides Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Merck KGaA
Thermo Fisher Scientific
Creative Biolabs
Danaher Corporation
Eurofins Scientific SE
Agilent Technologies, Inc.
GE Healthcare
Kaneka Eurogentec S.A.
GeneDesign, Inc.
LGC Biosearch Technologies
Bio-synthesis Inc.
GeneWorks Pty Ltd
Integrated DNA Technologies, Inc
BioAutomation
Twist Bioscience

Related Reports

Global Synthetic Oligonucleotides Supply, Demand and Key Producers, 2023-2029

Global Synthetic Oligonucleotides Supply, Demand and Key Producers, 2023-2029

date 17 Feb 2023

date Medical Care

The global Synthetic Oligonucleotides market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Synthetic Oligonucleotides Supply, Demand and Key Producers, 2024-2030

Global Synthetic Oligonucleotides Supply, Demand and Key Producers, 2024-2030

date 29 Feb 2024

date Medical Care

The global Synthetic Oligonucleotides market size is expected to reach $ 14230 million by 2030, rising at a market growth of 10.7% CAGR during the forecast period (2024-2030).

Product Tags

Synthetic Oligonucleotides

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>